RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin
Author(s) -
Nianping Feng
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s27581
Subject(s) - lactic acid , nanoparticle , pharmacokinetics , materials science , particle size , surface modification , in vitro , nuclear chemistry , pharmacology , biophysics , nanotechnology , chemistry , medicine , biochemistry , bacteria , genetics , biology
The purpose of this study was to develop an active targeting strategy to improve the therapeutic antitumor efficacy of oridonin (ORI), the main active ingredient in the medicinal herb Rabdosia rubescens.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom